Berenberg Bank Reiterates Buy Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reaffirmed by equities research analysts at Berenberg Bank in a research note issued to investors on Tuesday, Marketbeat.com reports. They currently have a GBX 300 ($3.67) target price on the stock. Berenberg Bank’s price target suggests a potential upside of 33.33% from the stock’s previous close.

Advanced Medical Solutions Group Trading Up 3.2 %

Shares of Advanced Medical Solutions Group stock opened at GBX 225 ($2.75) on Tuesday. The company’s fifty day simple moving average is GBX 204.11 and its 200-day simple moving average is GBX 220.21. The company has a market cap of £482.74 million, a price-to-earnings ratio of 4,500.00, a PEG ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. Advanced Medical Solutions Group has a 1 year low of GBX 176.60 ($2.16) and a 1 year high of GBX 275.83 ($3.38).

Insider Transactions at Advanced Medical Solutions Group

In related news, insider Eddie Johnson sold 34,235 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of GBX 218 ($2.67), for a total value of £74,632.30 ($91,349.20). 3.12% of the stock is currently owned by corporate insiders.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.